We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$39.7B
AUM Growth
+$3.58B
(+9.9%)
Cap. Flow
+$2.92B
Cap. Flow
% of AUM
7.34%
Top 10 Holdings %
Top 10 Hldgs %
15.27%
Holding
2,330
New
168
Increased
907
Reduced
894
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Williams Companies
WMB
|
+$260M |
| 2 |
Entergy
ETR
|
+$254M |
| 3 |
Philip Morris
PM
|
+$217M |
| 4 |
Pfizer
PFE
|
+$184M |
| 5 |
LyondellBasell Industries
LYB
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$404M |
| 2 |
Merck
MRK
|
+$328M |
| 3 |
Gilead Sciences
GILD
|
+$142M |
| 4 |
Clorox
CLX
|
+$121M |
| 5 |
Align Technology
ALGN
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.7% |
| 2 | Technology | 13.73% |
| 3 | Financials | 11.58% |
| 4 | Consumer Staples | 9.23% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
RCM Technologies
RCMT
$278M
| $1.75K | ﹤0.01% |
151
+116
| +331% | +$1.53K |
|
2002
A10 Networks
ATEN
$1.94B
| $1.74K | ﹤0.01% |
112
-147
| -57% | -$2.24K |
|
2003
Tango Therapeutics
TNGX
$4.03B
| $1.63K | ﹤0.01% |
+412
| New | +$2.39K |
|
2004
Agilysys
AGYS
$2.95B
| $1.57K | ﹤0.01% |
19
-5
| -21% | -$404 |
|
2005
News Corp Class B
NWS
$18.1B
| $1.55K | ﹤0.01% |
89
-1,064
| -92% | -$19.6K |
|
2006
Avista
AVA
$3.04B
| $1.53K | ﹤0.01% |
36
-2
| -5% | -$83 |
|
|
HOOK
2007
DELISTED
HOOKIPA Pharma
HOOK
| $1.52K | ﹤0.01% |
206
-64
| -24% | -$573 |
|
|
TECX
2008
Tectonic Therapeutic
TECX
$557M
| $1.51K | ﹤0.01% |
126
-472
| -79% | -$6.57K |
|
|
FXLV
2009
DELISTED
F45 Training Holdings Inc.
FXLV
| $1.49K | ﹤0.01% |
+1,287
| New | +$3.06K |
|
2010
Oramed Pharmaceuticals
ORMP
$192M
| $1.49K | ﹤0.01% |
+684
| New | +$2.17K |
|
|
KLR
2011
DELISTED
Kaleyra, Inc.
KLR
| $1.49K | ﹤0.01% |
901
+135
| +18% | +$428 |
|
|
RAIN
2012
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $1.45K | ﹤0.01% |
+166
| New | +$1.53K |
|
|
MTEM
2013
DELISTED
Molecular Templates, Inc.
MTEM
| $1.43K | ﹤0.01% |
251
| – | – |
|
2014
Aligos Therapeutics
ALGS
$31.2M
| $1.42K | ﹤0.01% |
65
-62
| -49% | -$2.37K |
|
|
WHWK
2015
Whitehawk Therapeutics
WHWK
$233M
| $1.38K | ﹤0.01% |
191
-14,679
| -99% | -$157K |
|
2016
Neuronetics
STIM
$213M
| $1.35K | ﹤0.01% |
465
-142
| -23% | -$716 |
|
2017
Neurogene
NGNE
$674M
| $1.33K | ﹤0.01% |
95
-130
| -58% | -$1.52K |
|
|
AFIB
2018
DELISTED
Acutus Medical Inc
AFIB
| $1.31K | ﹤0.01% |
1,737
-115
| -6% | -$150 |
|
2019
First Community Bankshares
FCBC
$902M
| $1.28K | ﹤0.01% |
51
| – | – |
|
2020
Quince Therapeutics
QNCX
$29.3M
| $1.25K | ﹤0.01% |
4
-1,248
| -100% | -$244K |
|
|
SGTX
2021
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $1.19K | ﹤0.01% |
98
-119
| -55% | -$1.24K |
|
2022
American Superconductor
AMSC
$1.34B
| $1.18K | ﹤0.01% |
241
-150
| -38% | -$754 |
|
2023
Viemed Healthcare
VMD
$333M
| $1.18K | ﹤0.01% |
+122
| New | +$1.06K |
|
2024
Ocular Therapeutix
OCUL
$2.24B
| $1.16K | ﹤0.01% |
220
-141
| -39% | -$670 |
|
2025
Shattuck Labs
STTK
$599M
| $1.16K | ﹤0.01% |
394
-728
| -65% | -$2.57K |
|
Similar funds
Federated Hermes's Q1 2023 Portfolio in Review
As of Q1 2023, Federated Hermes held 2,330 positions worth $39.7B, up 9.9% from $36.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.92B of net new capital in Q1 2023, opening 168 new positions and adding to 907 existing holdings. Its largest new stake was Rogers Corp: 345,466 shares worth $56.5M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 23% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $404M trimmed.
- Federated Hermes's largest Q1 2023 buy was Rogers Corp: 345,466 shares worth $56.5M.
- Federated Hermes added most to Williams Companies in Q1 2023, an estimated $260M increase.
- Federated Hermes's biggest Q1 2023 reduction was JPMorgan Chase, cutting an estimated $404M.
- Federated Hermes fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $56.3M.
- Federated Hermes's ten largest holdings make up 15% of its $39.7B portfolio in Q1 2023.
- Federated Hermes opened 168 new positions and closed 217 in Q1 2023.
- Federated Hermes's portfolio value rose 9.9% quarter-over-quarter to $39.7B.
Based on Federated Hermes's 13F filing for Q1 2023, filed 8 May 2023.